KH6.F - NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV
Piper Sandler CompaniesEstimate Increase

Updated Dyslipidemia Guidelines Support Earlier Treatment & Biomarker Testing

公司
KH6.F
日期
2026-03-16
分析师
Yasmeen Rahimi, Ph.D.
页数
6
需要登录
请登录后购买研报或生成音频内容。
Updated Dyslipidemia Guidelines Support Earlier Treatment & Biomarker Testing - NewAmsterdam Pharma Company NV (KH6.F) | 研报说 MoneyTalk | 研报说